Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Other Non-Current Assets of $36.8 million for Q2 2026, up 7.31% year-over-year from $34.3 million in Q2 2025, and up 34.96% quarter-over-quarter from $27.3 million in Q1 2026.
Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Other Non-Current Assets for 6 consecutive years, with $36.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 7.31% year-over-year to $36.8 million; the TTM figure through Jun 2026 stood at $36.8 million (up 7.31% YoY), while the FY2025 annual figure was $27.8 million, down 8.17% from the prior year.
- Other Non-Current Assets improved to $36.8 million in Q2 2026 per JUSHF's latest filing, from $27.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $37.3 million in Q2 2023 and bottomed at $27.3 million in Q1 2026.
- Historically, Other Non-Current Assets has averaged $31.0 million across 5 years, with a median of $30.3 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 5279.62% — and 2024, when it slipped 22.25%.
- Jushi Holdings' Other Non-Current Assets stood at $28.2 million in 2022, then gained by 7.49% to $30.4 million in 2023, then dropped by 0.28% to $30.3 million in 2024, then declined by 8.17% to $27.8 million in 2025, then jumped by 32.29% to $36.8 million in 2026.
- Business Quant data shows JUSHF's Other Non-Current Assets at $36.8 million in Q2 2026, $27.3 million in Q1 2026, and $27.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 13.00 Mn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 36.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.78 Mn |
| Mar 31, 2026 | 27.25 Mn |
| Dec 31, 2025 | 27.80 Mn |
| Sep 30, 2025 | 31.63 Mn |
| Jun 30, 2025 | 34.27 Mn |
| Mar 31, 2025 | 30.88 Mn |
| Dec 31, 2024 | 30.27 Mn |
| Sep 30, 2024 | 30.14 Mn |
| Jun 30, 2024 | 28.98 Mn |
| Mar 31, 2024 | 30.32 Mn |
| Dec 31, 2023 | 30.36 Mn |
| Sep 30, 2023 | 34.23 Mn |
| Jun 30, 2023 | 37.27 Mn |
| Mar 31, 2023 | 29.31 Mn |
| Dec 31, 2022 | 28.24 Mn |
| Sep 30, 2022 | 28.15 Mn |
| Jun 30, 2022 | 30.48 Mn |
| Dec 31, 2021 | 525,000.00 |